US Stock MarketDetailed Quotes

Denali Therapeutics (DNLI)

Watchlist
  • 20.570
  • -0.140-0.68%
Close Apr 17 16:00 ET
  • 20.570
  • 0.0000.00%
Post 20:01 ET
3.26BMarket Cap-6.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics (DNLI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-18.67%-412.6M
-17.71%-98.54M
-81.43%-107.3M
17.45%-75.3M
-15.71%-131.47M
2.88%-347.69M
15.15%-83.72M
32.31%-59.14M
19.39%-91.22M
-93.22%-113.62M
Net income from continuing operations
-21.23%-512.54M
-12.02%-128.55M
-18.39%-126.9M
-25.34%-124.12M
-30.62%-132.97M
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
Operating gains losses
----
----
----
----
----
---14.54M
--0
--0
--0
---14.54M
Depreciation and amortization
64.72%14.81M
44.41%3.78M
70.21%3.86M
103.71%3.96M
48.57%3.21M
-46.24%8.99M
20.30%2.62M
2.35%2.27M
-15.01%1.94M
-78.48%2.16M
Other non cash items
-8.03%-4.4M
-4.48%-1.1M
-9.06%-1.14M
-9.13%-1.11M
-9.61%-1.05M
-9.60%-4.07M
-9.84%-1.05M
-9.61%-1.05M
-9.81%-1.02M
-9.12%-957K
Change In working capital
-99.12%149K
-52.48%5.02M
-120.50%-6.22M
385.41%23.29M
-38.73%-21.93M
105.84%16.94M
80.46%10.56M
788.70%30.35M
97.39%-8.16M
-173.27%-15.81M
-Change in prepaid assets
78.23%-540K
1,104.83%1.75M
-92.30%1.36M
1,689.62%24.96M
-52.44%-28.61M
39.42%-2.48M
102.42%145K
20,257.47%17.71M
-143.47%-1.57M
-948.97%-18.77M
-Change in payables and accrued expense
-250.59%-7.06M
698.91%9.32M
-110.78%-2.18M
70.00%-5.08M
-408.39%-9.12M
-7.76%4.69M
-112.72%-1.56M
726.60%20.21M
38.29%-16.93M
-87.43%2.96M
-Change in other current assets
28.03%772K
-129.93%-533K
-45.76%-1.72M
--3.97M
---943K
--603K
--1.78M
---1.18M
--0
--0
-Change in other current liabilities
--0
----
----
----
----
--0
----
----
----
----
-Change in other working capital
-50.65%6.97M
-154.17%-5.52M
42.35%-3.69M
---557K
--16.73M
104.86%14.13M
--10.19M
-404.42%-6.4M
----
----
Cash from discontinued investing activities
Operating cash flow
-18.67%-412.6M
-17.71%-98.54M
-81.43%-107.3M
17.45%-75.3M
-15.71%-131.47M
2.88%-347.69M
15.15%-83.72M
32.31%-59.14M
19.39%-91.22M
-93.22%-113.62M
Investing cash flow
Cash flow from continuing investing activities
387.62%255.28M
-87.94%20.77M
-38.25%57.83M
60.23%157.94M
104.14%18.75M
-135.60%-88.76M
135.75%172.21M
-7.19%93.66M
-41.35%98.57M
-388.80%-453.19M
Net PPE purchase and sale
40.28%-9.5M
70.07%-1.52M
135.48%1.38M
10.61%-4.28M
-136.19%-5.08M
-22.98%-15.91M
-127.83%-5.09M
-87.81%-3.88M
18.19%-4.79M
22.83%-2.15M
Net investment purchase and sale
463.49%264.78M
-87.43%22.29M
-42.12%56.45M
56.95%162.21M
105.28%23.83M
-127.78%-72.84M
135.51%177.3M
-5.28%97.54M
-40.57%103.36M
-401.55%-451.04M
Cash from discontinued investing activities
Investing cash flow
387.62%255.28M
-87.94%20.77M
-38.25%57.83M
60.23%157.94M
104.14%18.75M
-135.60%-88.76M
135.75%172.21M
-7.19%93.66M
-41.35%98.57M
-388.80%-453.19M
Financing cash flow
Cash flow from continuing financing activities
-60.93%189.22M
4,709.72%192.13M
95.81%-778K
-75.98%1.62M
-100.75%-3.76M
2,617.76%484.3M
-188.59%-4.17M
-844.74%-18.56M
-25.09%6.76M
31,089.21%500.28M
Net issuance payments of debt
74.74%-8.17M
99.81%-16K
94.33%-1.36M
---2.43M
---4.36M
---32.34M
---8.32M
---24.02M
--0
--0
Net common stock issuance
-62.09%189.25M
--189.25M
--0
--0
--0
--499.25M
--0
--0
--0
--499.25M
Proceeds from stock option exercised by employees
-51.35%8.46M
-22.41%3.22M
-89.31%583K
-39.95%4.06M
-41.78%595K
-2.42%17.39M
-11.69%4.16M
118.94%5.46M
-25.09%6.76M
-36.28%1.02M
Net other financing activities
---324K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-60.93%189.22M
4,709.72%192.13M
95.81%-778K
-75.98%1.62M
-100.75%-3.76M
2,617.76%484.3M
-188.59%-4.17M
-844.74%-18.56M
-25.09%6.76M
31,089.21%500.28M
Net cash flow
Beginning cash position
37.19%176.54M
2.01%94.07M
89.25%144.31M
-3.37%60.05M
37.19%176.54M
-41.39%128.68M
-38.36%92.21M
-42.90%76.25M
-10.75%62.15M
-41.39%128.68M
Current changes in cash
-33.35%31.9M
35.62%114.36M
-414.87%-50.24M
497.38%84.26M
-75.08%-116.48M
152.67%47.85M
503.37%84.32M
-0.51%15.96M
-77.93%14.11M
55.62%-66.53M
End cash Position
18.07%208.43M
18.07%208.43M
2.01%94.07M
89.25%144.31M
-3.37%60.05M
37.19%176.54M
37.19%176.54M
-38.36%92.21M
-42.90%76.25M
-10.75%62.15M
Free cash flow
-16.09%-422.1M
-12.67%-100.06M
-68.06%-105.92M
17.11%-79.58M
-17.95%-136.55M
1.97%-363.61M
11.98%-88.81M
29.53%-63.02M
19.34%-96.01M
-87.97%-115.77M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -18.67%-412.6M-17.71%-98.54M-81.43%-107.3M17.45%-75.3M-15.71%-131.47M2.88%-347.69M15.15%-83.72M32.31%-59.14M19.39%-91.22M-93.22%-113.62M
Net income from continuing operations -21.23%-512.54M-12.02%-128.55M-18.39%-126.9M-25.34%-124.12M-30.62%-132.97M-191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M
Operating gains losses -----------------------14.54M--0--0--0---14.54M
Depreciation and amortization 64.72%14.81M44.41%3.78M70.21%3.86M103.71%3.96M48.57%3.21M-46.24%8.99M20.30%2.62M2.35%2.27M-15.01%1.94M-78.48%2.16M
Other non cash items -8.03%-4.4M-4.48%-1.1M-9.06%-1.14M-9.13%-1.11M-9.61%-1.05M-9.60%-4.07M-9.84%-1.05M-9.61%-1.05M-9.81%-1.02M-9.12%-957K
Change In working capital -99.12%149K-52.48%5.02M-120.50%-6.22M385.41%23.29M-38.73%-21.93M105.84%16.94M80.46%10.56M788.70%30.35M97.39%-8.16M-173.27%-15.81M
-Change in prepaid assets 78.23%-540K1,104.83%1.75M-92.30%1.36M1,689.62%24.96M-52.44%-28.61M39.42%-2.48M102.42%145K20,257.47%17.71M-143.47%-1.57M-948.97%-18.77M
-Change in payables and accrued expense -250.59%-7.06M698.91%9.32M-110.78%-2.18M70.00%-5.08M-408.39%-9.12M-7.76%4.69M-112.72%-1.56M726.60%20.21M38.29%-16.93M-87.43%2.96M
-Change in other current assets 28.03%772K-129.93%-533K-45.76%-1.72M--3.97M---943K--603K--1.78M---1.18M--0--0
-Change in other current liabilities --0------------------0----------------
-Change in other working capital -50.65%6.97M-154.17%-5.52M42.35%-3.69M---557K--16.73M104.86%14.13M--10.19M-404.42%-6.4M--------
Cash from discontinued investing activities
Operating cash flow -18.67%-412.6M-17.71%-98.54M-81.43%-107.3M17.45%-75.3M-15.71%-131.47M2.88%-347.69M15.15%-83.72M32.31%-59.14M19.39%-91.22M-93.22%-113.62M
Investing cash flow
Cash flow from continuing investing activities 387.62%255.28M-87.94%20.77M-38.25%57.83M60.23%157.94M104.14%18.75M-135.60%-88.76M135.75%172.21M-7.19%93.66M-41.35%98.57M-388.80%-453.19M
Net PPE purchase and sale 40.28%-9.5M70.07%-1.52M135.48%1.38M10.61%-4.28M-136.19%-5.08M-22.98%-15.91M-127.83%-5.09M-87.81%-3.88M18.19%-4.79M22.83%-2.15M
Net investment purchase and sale 463.49%264.78M-87.43%22.29M-42.12%56.45M56.95%162.21M105.28%23.83M-127.78%-72.84M135.51%177.3M-5.28%97.54M-40.57%103.36M-401.55%-451.04M
Cash from discontinued investing activities
Investing cash flow 387.62%255.28M-87.94%20.77M-38.25%57.83M60.23%157.94M104.14%18.75M-135.60%-88.76M135.75%172.21M-7.19%93.66M-41.35%98.57M-388.80%-453.19M
Financing cash flow
Cash flow from continuing financing activities -60.93%189.22M4,709.72%192.13M95.81%-778K-75.98%1.62M-100.75%-3.76M2,617.76%484.3M-188.59%-4.17M-844.74%-18.56M-25.09%6.76M31,089.21%500.28M
Net issuance payments of debt 74.74%-8.17M99.81%-16K94.33%-1.36M---2.43M---4.36M---32.34M---8.32M---24.02M--0--0
Net common stock issuance -62.09%189.25M--189.25M--0--0--0--499.25M--0--0--0--499.25M
Proceeds from stock option exercised by employees -51.35%8.46M-22.41%3.22M-89.31%583K-39.95%4.06M-41.78%595K-2.42%17.39M-11.69%4.16M118.94%5.46M-25.09%6.76M-36.28%1.02M
Net other financing activities ---324K------------------------------------
Cash from discontinued financing activities
Financing cash flow -60.93%189.22M4,709.72%192.13M95.81%-778K-75.98%1.62M-100.75%-3.76M2,617.76%484.3M-188.59%-4.17M-844.74%-18.56M-25.09%6.76M31,089.21%500.28M
Net cash flow
Beginning cash position 37.19%176.54M2.01%94.07M89.25%144.31M-3.37%60.05M37.19%176.54M-41.39%128.68M-38.36%92.21M-42.90%76.25M-10.75%62.15M-41.39%128.68M
Current changes in cash -33.35%31.9M35.62%114.36M-414.87%-50.24M497.38%84.26M-75.08%-116.48M152.67%47.85M503.37%84.32M-0.51%15.96M-77.93%14.11M55.62%-66.53M
End cash Position 18.07%208.43M18.07%208.43M2.01%94.07M89.25%144.31M-3.37%60.05M37.19%176.54M37.19%176.54M-38.36%92.21M-42.90%76.25M-10.75%62.15M
Free cash flow -16.09%-422.1M-12.67%-100.06M-68.06%-105.92M17.11%-79.58M-17.95%-136.55M1.97%-363.61M11.98%-88.81M29.53%-63.02M19.34%-96.01M-87.97%-115.77M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -